Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +23.33%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +22.84%
#5 Fabric Protocol Fabric Protocol +19.88%
#6 Nockchain Nockchain +18.95%
#7 Bedrock Bedrock +18.65%
#8 Victoria VR Victoria VR +17.20%
#9 Velvet Velvet +12.00%
#10 Perle Perle +11.29%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
BioSenic S.A. BioSenic S.A.

BioSenic S.A.

BIOS
Rank in Stocks #37641
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium,... BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
Share Price
$0.00237231
Last synced: 2026-06-22
Market Cap
$1.55M
Change (1 day)
0.00%
Change (1 year)
-18.94%
Country
BE
Trade BioSenic S.A. (BIOS)

Category

Healthcare
Revenue for BioSenic S.A. (BIOS)
Revenue in Aug 2026 TTM: 0
According to BioSenic S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioSenic S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE